{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:27:39Z","timestamp":1792787259581,"version":"4.5.0"},"reference-count":44,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T00:00:00Z","timestamp":1696464000000},"content-version":"unspecified","delay-in-days":4,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"UKRI\/NIHR funded Multimorbidity Mechanism and Therapeutics Research Collaborative","award":["MR\/V033867\/1"],"award-info":[{"award-number":["MR\/V033867\/1"]}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["AA\/18\/6\/34223"],"award-info":[{"award-number":["AA\/18\/6\/34223"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["FS\/17\/70\/33482"],"award-info":[{"award-number":["FS\/17\/70\/33482"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"name":"UCL NIHR Biomedical Research Centre","award":["NIHR203328"],"award-info":[{"award-number":["NIHR203328"]}]},{"name":"NIHR Senior Investigators","award":["NF-SI-0616-10066"],"award-info":[{"award-number":["NF-SI-0616-10066"]}]},{"name":"NIHR Senior Investigators","award":["NIHR202383"],"award-info":[{"award-number":["NIHR202383"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["bmjmed"],"accepted":{"date-parts":[[2023,8,31]]},"published-print":{"date-parts":[[2023,10]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To clarify the performance of polygenic risk scores in population screening, individual risk prediction, and population risk stratification.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Secondary analysis of data in the Polygenic Score Catalog.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>Polygenic Score Catalog, April 2022. Secondary analysis of 3915 performance metric estimates for 926 polygenic risk scores for 310 diseases to generate estimates of performance in population screening, individual risk, and population risk stratification.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>Individuals contributing to the published studies in the Polygenic Score Catalog.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main outcome measures<\/jats:title>\n                    <jats:p>\n                      Detection rate for a 5% false positive rate (DR\n                      <jats:sub>5<\/jats:sub>\n                      ) and the population odds of becoming affected given a positive result; individual odds of becoming affected for a person with a particular polygenic score; and odds of becoming affected for groups of individuals in different portions of a polygenic risk score distribution. Coronary artery disease and breast cancer were used as illustrative examples.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      For performance in population screening, median DR\n                      <jats:sub>5<\/jats:sub>\n                      for all polygenic risk scores and all diseases studied was 11% (interquartile range 8-18%). Median DR\n                      <jats:sub>5<\/jats:sub>\n                      was 12% (9-19%) for polygenic risk scores for coronary artery disease and 10% (9-12%) for breast cancer. The population odds of becoming affected given a positive results were 1:8 for coronary artery disease and 1:21 for breast cancer, with background 10\u2009year odds of 1:19 and 1:41, respectively, which are typical for these diseases at age 50. For individual risk prediction, the corresponding 10\u2009year odds of becoming affected for individuals aged 50 with a polygenic risk score at the 2.5th, 25th, 75th, and 97.5th centiles were 1:54, 1:29, 1:15, and 1:8 for coronary artery disease and 1:91, 1:56, 1:34, and 1:21 for breast cancer. In terms of population risk stratification, at age 50, the risk of coronary artery disease was divided into five groups, with 10\u2009year odds of 1:41 and 1:11 for the lowest and highest quintile groups, respectively. The 10\u2009year odds was 1:7 for the upper 2.5% of the polygenic risk score distribution for coronary artery disease, a group that contributed 7% of cases. The corresponding estimates for breast cancer were 1:72 and 1:26 for the lowest and highest quintile groups, and 1:19 for the upper 2.5% of the distribution, which contributed 6% of cases.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Polygenic risk scores performed poorly in population screening, individual risk prediction, and population risk stratification. Strong claims about the effect of polygenic risk scores on healthcare seem to be disproportionate to their performance.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjmed-2023-000554","type":"journal-article","created":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T20:00:30Z","timestamp":1697572830000},"page":"e000554","source":"Crossref","is-referenced-by-count":84,"title":["Performance of polygenic risk scores in screening, prediction, and risk stratification: secondary analysis of data in the Polygenic Score Catalog"],"prefix":"10.1136","volume":"2","author":[{"given":"Aroon D","family":"Hingorani","sequence":"first","affiliation":[{"name":"Institute of Cardiovascular Science, University College London, London, UK"},{"name":"British Heart Foundation Research Accelerator, University College London, London, UK"},{"name":"National Institute of Health Research Biomedical Research Centre, University College London Hospitals, London, UK"},{"name":"Health Data Research UK, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9781-9762","authenticated-orcid":false,"given":"Jasmine","family":"Gratton","sequence":"additional","affiliation":[{"name":"Institute of Cardiovascular Science, University College London, London, UK"},{"name":"British Heart Foundation Research Accelerator, University College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Finan","sequence":"additional","affiliation":[{"name":"Institute of Cardiovascular Science, University College London, London, UK"},{"name":"British Heart Foundation Research Accelerator, University College London, London, UK"},{"name":"National Institute of Health Research Biomedical Research Centre, University College London Hospitals, London, UK"},{"name":"Health Data Research UK, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A Floriaan","family":"Schmidt","sequence":"additional","affiliation":[{"name":"Institute of Cardiovascular Science, University College London, London, UK"},{"name":"National Institute of Health Research Biomedical Research Centre, University College London Hospitals, London, UK"},{"name":"Health Data Research UK, London, UK"},{"name":"University Medical Centre Utrecht, Utrecht, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riyaz","family":"Patel","sequence":"additional","affiliation":[{"name":"Institute of Cardiovascular Science, University College London, London, UK"},{"name":"British Heart Foundation Research Accelerator, University College London, London, UK"},{"name":"National Institute of Health Research Biomedical Research Centre, University College London Hospitals, London, UK"},{"name":"Health Data Research UK, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reecha","family":"Sofat","sequence":"additional","affiliation":[{"name":"Health Data Research UK, London, UK"},{"name":"Department of Pharmacology and Therapeutics, University of Liverpool, Liverpool, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie","family":"Kuan","sequence":"additional","affiliation":[{"name":"Institute of Cardiovascular Science, University College London, London, UK"},{"name":"British Heart Foundation Research Accelerator, University College London, London, UK"},{"name":"National Institute of Health Research Biomedical Research Centre, University College London Hospitals, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Langenberg","sequence":"additional","affiliation":[{"name":"Precision Healthcare University Research Institute, Queen Mary University of London, London, UK"},{"name":"Computational Medicine, Berlin Institute of Health at Charite Universitatzmedizin, Berlin, Germany"},{"name":"MRC Epidemiology Unit, University of Cambridge, Cambridge, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry","family":"Hemingway","sequence":"additional","affiliation":[{"name":"British Heart Foundation Research Accelerator, University College London, London, UK"},{"name":"National Institute of Health Research Biomedical Research Centre, University College London Hospitals, London, UK"},{"name":"Health Data Research UK, London, UK"},{"name":"Institute of Health Informatics, University College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan K","family":"Morris","sequence":"additional","affiliation":[{"name":"Population Health Research Institute, St George's University of London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas J","family":"Wald","sequence":"additional","affiliation":[{"name":"Institute of Health Informatics, University College London, London, UK"},{"name":"Population Health Research Institute, St George's University of London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2023,10,17]]},"reference":[{"key":"2025080501015822000_2.1.e000554.1","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1001\/jamapsychiatry.2020.3049","article-title":"From basic science to clinical application of polygenic risk scores: a primer","volume":"78","author":"Wray","year":"2021","journal-title":"JAMA Psychiatry"},{"key":"2025080501015822000_2.1.e000554.2","doi-asserted-by":"crossref","DOI":"10.1038\/s42003-018-0261-x","article-title":"A scientometric review of genome-wide association studies","volume":"2","author":"Mills","year":"2019","journal-title":"Commun Biol"},{"key":"2025080501015822000_2.1.e000554.3","doi-asserted-by":"publisher","DOI":"10.1038\/s41576-018-0018-x"},{"key":"2025080501015822000_2.1.e000554.4","unstructured":"GOV.UK . Genome UK: the future of healthcare. Available: https:\/\/www.gov.uk\/government\/publications\/genome-uk-the-future-of-healthcare [Accessed 24 Jan 2022]."},{"key":"2025080501015822000_2.1.e000554.5","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGEN.120.003304","article-title":"Integrated polygenic tool substantially enhances coronary artery disease prediction","volume":"14","author":"Riveros-Mckay","year":"2021","journal-title":"Circ Genom Precis Med"},{"key":"2025080501015822000_2.1.e000554.6","unstructured":"For health systems - Genomics plc, Available: https:\/\/www.genomicsplc.com\/precision-health\/health-systems\/ [Accessed 25 Aug 2022]."},{"key":"2025080501015822000_2.1.e000554.7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002546","article-title":"Cardiovascular disease: the rise of the genetic risk score","volume":"15","author":"Knowles","year":"2018","journal-title":"PLoS Med"},{"key":"2025080501015822000_2.1.e000554.8","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddz187"},{"key":"2025080501015822000_2.1.e000554.9","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03243-6"},{"key":"2025080501015822000_2.1.e000554.10","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01549-6"},{"key":"2025080501015822000_2.1.e000554.11","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.l5688","article-title":"Direct-to-consumer genetic testing","volume":"367","author":"Horton","year":"2019","journal-title":"BMJ"},{"key":"2025080501015822000_2.1.e000554.12","unstructured":"Genomics PLC. Available: https:\/\/www.genomicsplc.com\/ [Accessed 5 Jun 2022]."},{"key":"2025080501015822000_2.1.e000554.13","unstructured":"Allelica | Polygenic risk score. Available: https:\/\/www.allelica.com\/ [Accessed 5 Jun 2022]."},{"key":"2025080501015822000_2.1.e000554.14","unstructured":"The Guardian . NHS pilots genetic testing to predict risk of heart disease | Heart disease, Available: https:\/\/www.theguardian.com\/society\/2022\/jan\/17\/nhs-pilots-genetic-testing-to-predict-risk-of-heart-disease [Accessed 11 Sep 2022]."},{"key":"2025080501015822000_2.1.e000554.15","unstructured":"BBC News . Health of nation study calls on millions to sign up. Available: https:\/\/www.bbc.co.uk\/news\/health-63331805 [Accessed 25 Oct 2022]."},{"key":"2025080501015822000_2.1.e000554.16","doi-asserted-by":"publisher","DOI":"10.1038\/s41436-018-0418-5"},{"key":"2025080501015822000_2.1.e000554.17","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1001\/jamainternmed.2022.3171","article-title":"Incremental value of polygenic risk scores in primary prevention of coronary heart disease: a review","volume":"182","author":"Groenendyk","year":"2022","journal-title":"JAMA Intern Med"},{"key":"2025080501015822000_2.1.e000554.18","doi-asserted-by":"crossref","DOI":"10.1038\/s41698-021-00176-1","article-title":"Will polygenic risk scores for cancer ever be clinically useful?","volume":"5","author":"Sud","year":"2021","journal-title":"NPJ Precis Oncol"},{"key":"2025080501015822000_2.1.e000554.19","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2022-073149","article-title":"Realistic expectations are key to realising the benefits of polygenic scores","volume":"380","author":"Sud","year":"2023","journal-title":"BMJ"},{"key":"2025080501015822000_2.1.e000554.20","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-021-00783-5"},{"key":"2025080501015822000_2.1.e000554.21","unstructured":"The Polygenic Score (PGS) Catalog. Available: https:\/\/www.pgscatalog.org\/"},{"key":"2025080501015822000_2.1.e000554.22","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1177\/09691413231163128","article-title":"Guidance on terminology","volume":"30","author":"Wald","year":"2023","journal-title":"J Med Screen"},{"key":"2025080501015822000_2.1.e000554.23","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2010.378"},{"key":"2025080501015822000_2.1.e000554.24","doi-asserted-by":"publisher","DOI":"10.1177\/0969141313517497"},{"key":"2025080501015822000_2.1.e000554.25","doi-asserted-by":"crossref","unstructured":"Wald N , Leck I . Antenatal and neonatal screening. 2000. doi:10.1093\/acprof:oso\/9780192628268.001.0001","DOI":"10.1093\/acprof:oso\/9780192628268.001.0001"},{"key":"2025080501015822000_2.1.e000554.26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003498","article-title":"Polygenic risk scores in cardiovascular risk prediction: a cohort study and modelling analyses","volume":"18","author":"Sun","year":"2021","journal-title":"PLoS Med"},{"key":"2025080501015822000_2.1.e000554.27","unstructured":"NICE . Overview | Cardiovascular disease: risk assessment and reduction, including lipid modification | Guidance, Available: https:\/\/www.nice.org.uk\/guidance\/cg181 [Accessed 5 Jan 2022]."},{"key":"2025080501015822000_2.1.e000554.28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0018742","article-title":"Screening for future cardiovascular disease using age alone compared with multiple risk factors and age","volume":"6","author":"Wald","year":"2011","journal-title":"PLoS One"},{"key":"2025080501015822000_2.1.e000554.29","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.326.7404.1419"},{"key":"2025080501015822000_2.1.e000554.30","unstructured":"Breast cancer risk in American women - NCI. Available: https:\/\/www.cancer.gov\/types\/breast\/risk-fact-sheet [Accessed 25 Aug 2022]."},{"key":"2025080501015822000_2.1.e000554.31","doi-asserted-by":"publisher","DOI":"10.1001\/jama.293.10.1245"},{"key":"2025080501015822000_2.1.e000554.32","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.324.7353.1570"},{"key":"2025080501015822000_2.1.e000554.33","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/14.1.32"},{"key":"2025080501015822000_2.1.e000554.34","doi-asserted-by":"publisher","DOI":"10.1038\/nrcardio.2011.6"},{"key":"2025080501015822000_2.1.e000554.35","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.319.7224.1562"},{"key":"2025080501015822000_2.1.e000554.36","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.c6244","article-title":"How should we balance individual and population benefits of statins for preventing cardiovascular disease","volume":"342","author":"Hingorani","year":"2010","journal-title":"BMJ"},{"key":"2025080501015822000_2.1.e000554.37","unstructured":"Winyard G . SMAC statement on the use of statins. London: Department of Health, 1997."},{"key":"2025080501015822000_2.1.e000554.38","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2019.03.009"},{"key":"2025080501015822000_2.1.e000554.39","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.e5793","article-title":"Prognosis research strategy (PROGRESS) 4: stratified medicine research","volume":"346","author":"Hingorani","year":"2013","journal-title":"BMJ"},{"key":"2025080501015822000_2.1.e000554.40","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/S1470-2045(23)00156-0","article-title":"Utility of polygenic risk scores in UK cancer screening: a modelling analysis","volume":"24","author":"Huntley","year":"2023","journal-title":"Lancet Oncol"},{"key":"2025080501015822000_2.1.e000554.41","unstructured":"Polygenic risk scores - Genomics Plc. Available: https:\/\/www.genomicsplc.com\/resources\/polygenic-risk-scores\/ [Accessed 11 Nov 2021]."},{"key":"2025080501015822000_2.1.e000554.42","unstructured":"Direct-to-consumer genomic testing: government response to the committee\u2019s first report - science and technology committee - house of commons. Available: https:\/\/publications.parliament.uk\/pa\/cm5802\/cmselect\/cmsctech\/805\/80502.htm [Accessed 10 Jan 2022]."},{"key":"2025080501015822000_2.1.e000554.43","unstructured":"RSS - working group on diagnostic tests. Available: https:\/\/rss.org.uk\/policy-campaigns\/policy-groups\/working-group-on-diagnostic-tests\/ [Accessed 26 Jun 2023]."},{"key":"2025080501015822000_2.1.e000554.44","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a039230","article-title":"Human genomics and drug development","volume":"12","author":"Schmidt","year":"2022","journal-title":"Cold Spring Harb Perspect Med"}],"container-title":["BMJ Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjmed-2023-000554","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T08:02:09Z","timestamp":1754380929000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjmedicine.bmj.com\/lookup\/doi\/10.1136\/bmjmed-2023-000554"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,10,17]]},"published-print":{"date-parts":[[2023,10]]}},"alternative-id":["10.1136\/bmjmed-2023-000554"],"URL":"https:\/\/doi.org\/10.1136\/bmjmed-2023-000554","relation":{},"ISSN":["2754-0413"],"issn-type":[{"value":"2754-0413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10]]}}}